Literature DB >> 31340182

Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children.

Mahmut Demir1, Halil Kazanasmaz2.   

Abstract

OBJECTIVES: In this study, we aimed at identifying community and hospital-induced uropathogens isolated in urinary tract infection (UTI) determining the regional antibiotic resistance and the antibiotic preferences in empirical treatment in Sanliurfa/Turkey.
METHODS: The urinary culture results of the 842 paediatric patients, who were aged between 0 and 18 years, admitted to Department of Pediatrics, Harran University Medi-cal Faculty Hospital, Sanliurfa, Turkey with UTI complaints, diagnosed with UTI and in whose urine cultures production was detected, were retrospectively evaluated. Age, gender, clinical findings and culture results of the patients were examined in terms of reproducing pathogens, the frequency of their being community and hospital induced, Extended Spectrum Beta Lactamase production of reproduced pathogens, sensitivity and resistance to antibiotics.
RESULTS: A total of 842 patients, 472 (56.1%) girl were included in the study. According to the results of urine culture, Escherichia coli was detected in (58.9%) of the patients, Klebsiella (17.9%) and Proteus (15.8%). While high resistance to ampicillin (87.3%), cefuroxime (71.6%) and trimethoprim-sulfamethoxazole (60.8%) was found for all microorganisms, the lowest resistance to nitrofurantoin (21.4%), piperacillin/tazobactam (19.1), imipenem (8.6%), meropenem (8.8%), amikacin (6.2%) and cefoperazone/sulbactam (CSL) (4.7%) were determined in descending order. Resistance rates were higher in inpatients with UTI than in outpatients.
CONCLUSIONS: We think that the most appropriate antibiotic to be chosen for the outpatients for empirical treatment in all age groups in our region, is as oral nitrofurantoin and parenteral amikacin. Also the appropriate parenteral antibiotics that should be selected for the empirical treatment of inpatients UTI in all age groups are the CSL, amikacin and carbapenems.
Copyright © 2019 International Society for Antimicrobial Chemotherapy. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Children; Community-induced urinary tract infection; Hospital-induced urinary tract infection; Urinary tract infection

Mesh:

Substances:

Year:  2019        PMID: 31340182     DOI: 10.1016/j.jgar.2019.07.019

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  6 in total

1.  High prevalence of multidrug resistant uropathogens: A recent audit of antimicrobial susceptibility testing from a tertiary care hospital in Bangladesh.

Authors:  Chandrika Dasgupta; Md Abdur Rafi; Md Abdus Salam
Journal:  Pak J Med Sci       Date:  2020 Sep-Oct       Impact factor: 1.088

2.  Bacteriological profile of urinary tract infections and antibiotic susceptibility of Escherichia coli in Algeria.

Authors:  Nouara Ait-Mimoune; Houda Hassaine; Meriem Boulanoir
Journal:  Iran J Microbiol       Date:  2022-04

3.  Antibiotic Resistance of Uropathogens Isolated from Patients Hospitalized in District Hospital in Central Poland in 2020.

Authors:  Barbara Kot; Agata Grużewska; Piotr Szweda; Jolanta Wicha; Urszula Parulska
Journal:  Antibiotics (Basel)       Date:  2021-04-16

4.  Prevalence and Antibiotic Susceptibility of the Common Bacterial Uropathogen Among UTI Patients in French Medical Institute for Children.

Authors:  Mahdawi Joya; Ahmad Khalid Aalemi; Abdul Tawab Baryali
Journal:  Infect Drug Resist       Date:  2022-08-06       Impact factor: 4.177

5.  A retrospective study on the microbial spectrum and antibiogram of uropathogens in children in a secondary care hospital in Rural Vellore, South India.

Authors:  Cherryl Tryphena; Rani Diana Sahni; Sushil John; Shalini Jeyapaul; Anne George; Jasmine Helan
Journal:  J Family Med Prim Care       Date:  2021-04-29

6.  Susceptibility of hospital-acquired uropathogens to first-line antimicrobial agents at a tertiary health-care hospital, Saudi Arabia.

Authors:  Abdulaziz Alamri; Bahaeldin Hassan; Mohamed E Hamid
Journal:  Urol Ann       Date:  2021-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.